Compare AMP & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMP | GEHC |
|---|---|---|
| Founded | 1894 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.1B | 38.9B |
| IPO Year | 2005 | N/A |
| Metric | AMP | GEHC |
|---|---|---|
| Price | $499.75 | $80.27 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $536.78 | $88.27 |
| AVG Volume (30 Days) | 486.6K | ★ 3.2M |
| Earning Date | 01-29-2026 | 02-04-2026 |
| Dividend Yield | ★ 1.28% | 0.17% |
| EPS Growth | ★ 39.94 | 32.35 |
| EPS | ★ 36.43 | 4.83 |
| Revenue | $18,513,000,000.00 | ★ $20,246,000,000.00 |
| Revenue This Year | $2.37 | $6.42 |
| Revenue Next Year | $5.70 | $4.34 |
| P/E Ratio | ★ $13.74 | $16.62 |
| Revenue Growth | ★ 6.12 | 3.51 |
| 52 Week Low | $396.14 | $57.65 |
| 52 Week High | $582.05 | $94.80 |
| Indicator | AMP | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 50.95 | 43.66 |
| Support Level | $491.04 | $79.52 |
| Resistance Level | $511.79 | $83.21 |
| Average True Range (ATR) | 11.94 | 2.22 |
| MACD | -1.76 | -0.70 |
| Stochastic Oscillator | 30.89 | 17.36 |
Ameriprise Financial has evolved into a diversified financial services provider that generates roughly 65% of its operating income from advice and wealth management. With more than $1 trillion in segment assets under management and advisory at year-end 2024, and with roughly 10,000 affiliated advisors, Ameriprise is one of the larger US-based wealth managers. The firm also boasts a reasonably large asset management franchise in Columbia Threadneedle, which boasted $645 billion in assets under management at year-end 2024. The firm's third key segment is its retirement and protection services business, which sells insurance products to the firm's advisory clients. After eliminations, Ameriprise had $1.5 trillion in assets under management and advisory across segments at year-end 2024.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).